Search

Search Constraints

You searched for: Author/Creator Borek, Peter

Search Results

1. Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. (15th April 2021)

2. 207.2: Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago. Issue 12 (24th November 2021)

3. 307.5: Modified Approach Allowed for Improved Islet Allotransplantation Into Pre-vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Clinical Trial at University of Chicago. Issue 12 (24th November 2021)

4. 307.5: Modified Approach Allowed for Improved Islet Allotransplantation Into Pre-vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Clinical Trial at University of Chicago. Issue 12 (December 2021)

5. 207.2: Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago. Issue 12 (December 2021)

6. DURABLE EFFECT OF BETA CELL REPLACEMENT THERAPY ON IMPROVEMENT IN BLOOD GLUCOSE CONTROL AND PREVENTION OF PROGRESSION OF SECONDARY DIABETIC COMPLICATIONS IN NONUREMIC PATIENTS WITH TYPE 1 DIABETES MELLITUS AND PROBLEMATIC HYPOGLYCEMIA. Issue 3 (September 2020)

7. Long-term Stability of β-Cell Graft Function After Total Pancreatectomy and Islet Autotransplantation. Issue 1 (January 2021)